Norris Medicines Ltd vs Samrat Pharmachem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Norris Medicines Ltd is ₹ 14.25 as of 30 Apr 15:30 . The P/E Ratio of Norris Medicines Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Samrat Pharmachem Ltd changed from 7.9 on March 2021 to 13.6 on March 2025 . This represents a CAGR of 11.48% over 5 years The Market Cap of Norris Medicines Ltd changed from ₹ 6.5 crore on March 2021 to ₹ 16.78 crore on March 2025 . This represents a CAGR of 20.89% over 5 yearsThe Market Cap of Samrat Pharmachem Ltd changed from ₹ 42.02 crore on March 2021 to ₹ 96.63 crore on March 2025 . This represents a CAGR of 18.12% over 5 years The revenue of Norris Medicines Ltd for the Dec '25 is ₹ 3.27 crore as compare to the Sep '25 revenue of ₹ 2 crore. This represent the growth of 63.5% The revenue of Samrat Pharmachem Ltd for the Dec '25 is ₹ 63.83 crore as compare to the Sep '25 revenue of ₹ 78.92 crore. This represent the decline of -19.12% The ebitda of Norris Medicines Ltd for the Dec '25 is ₹ 0.95 crore as compare to the Sep '25 ebitda of ₹ -0.49 crore. This represent the decline of -293% The ebitda of Samrat Pharmachem Ltd for the Dec '25 is ₹ -0.26 crore as compare to the Sep '25 ebitda of ₹ -0.31 crore. This represent the decline of -16.13% The net profit of Norris Medicines Ltd changed from ₹ -0.37 crore to ₹ 0.7 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Samrat Pharmachem Ltd changed from ₹ 2.07 crore to ₹ -0.46 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Norris Medicines Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Samrat Pharmachem Ltd changed from 1.8 % on March 2022 to 4.35 % on March 2025 . This represents a CAGR of 24.68% over 4 years .

About Norris Medicines Ltd

Norris Medicines Limited was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments.
The Company was subsequently converted into Public Limited Company on March 7, 1992.
The unit expanded to manufacture Sterile dosage in form of Ampoules & Vials. The Company got into the business in the year 1990.
Commercial production of the formulation unit commenced in Nov.'91.
The production unit expanded to manufacture Sterile dosage in form of Ampoules & Vials.

About Samrat Pharmachem Ltd

Samrat Pharmachem Limited was incorporated on June 16, 1992 at Ankleshwar in Gujarat led by the Promoters, Mr. Lalit Mehta & Mr. Rajesh Mehta.
Since then, it envisioned to focus on lodine Derivatives as their core products.
The Company's principal activities are manufacturing and selling chemicals.
Company is a producer of pharmaceutical chemicals.
The intermediates produced are used in pharmaceutical and chemical industries.

FAQs for the comparison of Norris Medicines Ltd and Samrat Pharmachem Ltd

Which company has a larger market capitalization, Norris Medicines Ltd or Samrat Pharmachem Ltd?

Market cap of Norris Medicines Ltd is 14 Cr while Market cap of Samrat Pharmachem Ltd is 65 Cr

What are the key factors driving the stock performance of Norris Medicines Ltd and Samrat Pharmachem Ltd?

The stock performance of Norris Medicines Ltd and Samrat Pharmachem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Norris Medicines Ltd and Samrat Pharmachem Ltd?

As of May 3, 2026, the Norris Medicines Ltd stock price is INR ₹14.25. On the other hand, Samrat Pharmachem Ltd stock price is INR ₹211.1.

How do dividend payouts of Norris Medicines Ltd and Samrat Pharmachem Ltd compare?

To compare the dividend payouts of Norris Medicines Ltd and Samrat Pharmachem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.